Archives

by in
Entry Author Date Location
Seres Makes Push for First Drug, and IPO, of Microbiome Era 07/16/14 Boston
As Expected, Nurix Taps Into $25M for New Drug Discovery 05/22/14 San Francisco
In Pursuit of Hot Autoimmune Target, GSK and Academics Team Up 05/12/14 San Francisco
East Coast Biotech Roundup: Sarepta, Alkermes, Boston Biotech, & More 04/25/14 Boston
La Jolla Institute Extends 25-Year Partnership with Japanese Pharma 07/31/13 San Diego
XBiotech Takes Aim at Inflammation That Weakens Cancer Patients 05/17/13 Texas
End of the Road for Torrey Path as Founder Starts New Trail with Sequencethree 06/14/11 San Diego
Immune Design, Developer of New Vaccines, Adds Former Elan President as New CEO 04/27/11 Seattle
Adimab Inks Novartis Deal, GSK-Founded Tempero Pursues Hot Immunology Field, Metamark Gets $22M, & More Boston-Area Life Sciences News 07/16/10 Boston
Glaxo’s Tempero Pharma Advances on Hot Niche of Immunology 07/15/10 Boston
Nathan Myhrvold, Lee Hood Forge Longstanding Partnership at Nexus of IT and Biology 03/24/10 Seattle
Amgen’s Seattle and Boston Teams Seek to Boost Biotech Hit Rate 20 to 30 Percent 10/09/09 National
Biotech Pioneer Steve Gillis on Life as a VC, How Today’s Entrepreneurs Can Make It, and Seattle’s Future in Life Sciences (Part 1) 09/23/09 Seattle
Seattle-based Kineta, New Biotech Startup, Unveils Plan to Trigger Innate Immunity 12/09/08 Seattle
Paul Allen’s WWII Planes Show How Innovation Can Soar Ahead 08/21/08 Seattle
Immune Design Aiming To Make Vaccines That Work Better in a Single Shot 07/07/08 Seattle
Immune Design, Led By Star Scientists, Raises $18 Million To Build Vaccine Company 06/23/08 Seattle
Page 1 of 1